Johnson & Johnson MedTech Executive and Leadership Team

Gigi Chang, the Chief Financial Officer, Medtech (Canada) at Johnson & Johnson MedTech, directs all financial operations and strategic fiscal planning for the Canadian medical technology sector. Chang oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health and compliance across the region. This leadership position involves analyzing market trends and economic conditions specific to Canada to inform investment strategies and optimize resource allocation. Chang's responsibilities include managing relationships with financial institutions and stakeholders, driving profitability, and supporting the company's expansion initiatives within the Canadian market. By providing critical financial insights, Gigi Chang enables informed decision-making that aligns with Johnson & Johnson MedTech's broader objectives of delivering advanced healthcare solutions. The financial acumen applied by Chang is essential for sustaining growth and operational excellence in a dynamic healthcare landscape.

Tino Schweighoefer, the Chief Financial Officer, Monarch Platform at Johnson & Johnson MedTech, spearheads the financial strategy and management for the innovative Monarch Platform. Schweighoefer is responsible for all aspects of financial planning, analysis, and reporting related to this specific medical technology initiative. This includes driving financial performance, managing capital allocation, and ensuring the economic viability of the platform's development and deployment. Schweighoefer's role involves close collaboration with product development and commercial teams to align financial goals with technological advancements and market penetration strategies. By providing strategic financial guidance, Tino Schweighoefer supports the platform's growth and its contribution to Johnson & Johnson MedTech's mission of transforming medical interventions. The financial oversight provided by Schweighoefer is crucial for the sustained success and innovation of the Monarch Platform in the competitive healthcare technology market.

Ryan Benishake, the Co-Distributor Principal and President of One Medtech East, Inc. at Johnson & Johnson MedTech, leads distribution and sales operations for a key regional market. Benishake drives the commercial strategy and execution for medical technology products within the East region, focusing on expanding market reach and customer engagement. This role involves managing distributor relationships, optimizing supply chain logistics, and ensuring the effective delivery of advanced healthcare solutions to healthcare providers. Benishake's leadership is critical in translating Johnson & Johnson MedTech's innovative engineering into accessible medical devices for the region. By fostering strong partnerships and implementing effective sales strategies, Ryan Benishake contributes significantly to the company's B2B success and its mission to transform medical intervention capabilities. The operational focus of Benishake ensures efficient market penetration and customer satisfaction.

Steven Henn, the Global President, Biosurgery at Johnson & Johnson MedTech, directs the strategic vision and operational execution for the company's biosurgery portfolio worldwide. Henn oversees the development, manufacturing, and commercialization of advanced biosurgical products designed to enhance patient care and surgical outcomes. This leadership role involves driving innovation in areas such as hemostasis and tissue sealing, ensuring these solutions meet the evolving needs of healthcare professionals across diverse surgical specialties. Henn collaborates with R&D, marketing, and sales teams to expand market access and solidify Johnson & Johnson MedTech's position as a leader in biosurgical technologies. Through strategic leadership, Steven Henn champions the integration of purposeful technology to improve patient recovery and reduce complications, directly supporting the company's mission to transform medical intervention capabilities globally.

Oray Boston, the President, Worldwide of Trauma, Extremities, Craniomaxillofacial, Animal Health & Sports Medicine at Johnson & Johnson MedTech, leads a comprehensive portfolio of specialized medical solutions. Boston directs global strategy and commercial operations for trauma, reconstructive surgery, and veterinary medicine, driving innovation and market growth across these critical segments. This expansive role involves overseeing product development, market expansion in regions like North America and Asia, and ensuring the delivery of advanced medical devices that address complex patient needs. Oray Boston fosters cross-functional collaboration to integrate cutting-edge engineering with clinical requirements, enhancing surgical capabilities and patient recovery. The leadership provided by Boston is pivotal in advancing Johnson & Johnson MedTech's commitment to transforming medical interventions and improving quality of life through purposeful technology.

Devi Govender, the Worldwide President of Heart Recovery at Johnson & Johnson MedTech, spearheads the strategic direction and global commercialization of cardiac recovery technologies. Govender is responsible for advancing solutions that improve patient outcomes in cardiovascular care, driving innovation in devices and therapies aimed at heart recovery. This leadership position involves close collaboration with clinical teams, R&D, and global sales organizations to ensure the effective deployment of advanced medical technologies. Govender's focus is on expanding access to life-saving treatments and enhancing the capabilities of healthcare providers in managing cardiac conditions. By championing purposeful technology, Devi Govender directly contributes to Johnson & Johnson MedTech's mission of transforming medical intervention capabilities and improving global health outcomes in critical care areas.

Edward Zhou, the President (China) at Johnson & Johnson MedTech, directs the company's comprehensive medical technology operations and strategic growth within the vital Chinese market. Zhou oversees all aspects of business development, sales, and market penetration, ensuring alignment with Johnson & Johnson MedTech's global objectives and local regulatory requirements. This leadership role involves navigating the dynamic healthcare landscape in China, fostering key partnerships with healthcare institutions, and driving the adoption of advanced medical devices and solutions. Edward Zhou's strategic oversight is crucial for expanding the company's footprint and impact in one of the world's largest healthcare markets. By leading local initiatives, Zhou ensures that purposeful technology effectively addresses the specific needs of patients and clinicians in China, reinforcing the company's commitment to transforming medical intervention capabilities.

Yvan Francois, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech at Johnson & Johnson MedTech, directs critical operational support and strategic alignment for executive leadership. Francois manages key initiatives that enhance the efficiency and effectiveness of the worldwide chain operations within the medical technology division. This role involves close collaboration with senior leaders across North America, Europe, and Asia to ensure seamless execution of strategic plans. Francois's oversight extends to coordinating cross-functional projects that drive the company's mission of creating purposeful technology for medical interventions. By optimizing communication channels and facilitating decision-making processes, Yvan Francois ensures that executive directives translate into tangible operational improvements, directly supporting the company's goal of transforming medical capabilities globally. The scope of this position requires a deep understanding of the medical device industry and the complex global supply chains Johnson & Johnson MedTech operates within.

Randall Jones, the Chief Medical Officer at Johnson & Johnson MedTech, provides critical medical and scientific leadership, guiding the development and application of advanced healthcare solutions. Jones oversees clinical strategy, ensuring that all medical devices and technologies align with the highest standards of patient care and efficacy. This role involves translating clinical needs into actionable product development requirements and evaluating the medical impact of new innovations across various healthcare fields. Jones collaborates with research and development teams, regulatory affairs, and commercial units to champion evidence-based medical practices. By offering deep clinical insights, Randall Jones ensures that Johnson & Johnson MedTech's purposeful technology directly addresses unmet medical needs and enhances patient outcomes globally. The medical expertise Jones brings is fundamental to the company's commitment to transforming medical intervention capabilities.

Sanjeev Aggarwal, the Global Chief Medical Officer, Surgical Therapies Abiomed at Johnson & Johnson MedTech, directs the medical strategy and clinical vision for Abiomed's surgical therapy solutions. Aggarwal is instrumental in advancing the understanding and application of innovative cardiac technologies, ensuring they meet rigorous clinical standards and patient needs. This leadership position involves guiding clinical research, fostering physician education, and advocating for the adoption of advanced medical devices in surgical settings worldwide. Aggarwal collaborates closely with engineering, product management, and commercial teams to drive innovation and clinical excellence within surgical therapies. By providing unparalleled medical expertise, Sanjeev Aggarwal ensures that Abiomed's offerings significantly improve patient outcomes and transform cardiac care. The strategic medical direction provided by Aggarwal is vital to maintaining leadership in the highly specialized field of surgical interventions.